Back
Ultragenyx Pharmaceutical Stock Price Chart
Sell
41
RARE
Ultragenyx Pharmaceutical
Last Price:
40.38
Seasonality Move:
8.21%
7 Day Trial
ALL ACCESS PASS
$
7
- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing slight buying pressure.
Ultragenyx Pharmaceutical Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 41.13 | Sell |
| 20-day SMA: | 41.77 | Sell |
| 50-day SMA: | 44.49 | Sell |
| 200-day SMA: | 42.14 | Sell |
| 8-day EMA: | 40.89 | Sell |
| 20-day EMA: | 41.87 | Sell |
| 50-day EMA: | 43.73 | Sell |
| 200-day EMA: | 44.05 | Sell |
Ultragenyx Pharmaceutical Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.15 | Sell |
| Relative Strength Index (14 RSI): | 38.4 | Sell |
| Chaikin Money Flow: | 106656 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (40.86 - 43.66) | Sell |
| Bollinger Bands (100): | (42.61 - 49.17) | Sell |
Ultragenyx Pharmaceutical Technical Analysis
| May 13 | May 14 | May 15 | May 16 | May 17 | May 20 | May 21 | May 22 | May 23 | May 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 13 | 14 | 15 | 16 | 17 | 20 | 21 | 22 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Ultragenyx Pharmaceutical Stock
Is Ultragenyx Pharmaceutical Stock a Buy?
- Ultragenyx Pharmaceutical share price is 40.34 while RARE 8-day simple moving average is 41.13, which is a Sell signal.
- The stock price of RARE is 40.34 while Ultragenyx Pharmaceutical 20-day SMA is 41.77, which makes it a Sell.
- Ultragenyx Pharmaceutical 50-day simple moving average is 44.49 while RARE share price is 40.34, making it a Sell technically.
- RARE stock price is 40.34 and Ultragenyx Pharmaceutical 200-day simple moving average is 42.14, creating a Sell signal.
RARE Technical Analysis vs Fundamental Analysis
Sell
41
Ultragenyx Pharmaceutical (RARE)
is a Sell
Is Ultragenyx Pharmaceutical a Buy or a Sell?
-
Ultragenyx Pharmaceutical stock is rated a Sell
The current Ultragenyx Pharmaceutical [RARE] share price is $40.34. The Score for RARE is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
Ultragenyx Pharmaceutical Stock Info
Market Cap:
3.35B
Price in USD:
40.34
Share Volume:
407.48K
Ultragenyx Pharmaceutical 52-Week Range
52-Week High:
54.98
52-Week Low:
31.52
Sell
41
Ultragenyx Pharmaceutical (RARE)
is a Sell
Ultragenyx Pharmaceutical Share Price Forecast
-
What is the Ultragenyx Pharmaceutical stock price today?
The Ultragenyx Pharmaceutical stock price is 40.34 USD today. -
Will RARE stock go up or go down?
Ultragenyx Pharmaceutical> share price is forecast to RISE/FALL based on technical indicators -
Is Ultragenyx Pharmaceutical overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Ultragenyx Pharmaceutical is overvalued.
Is Ultragenyx Pharmaceutical Stock a Buy?
- Ultragenyx Pharmaceutical share price is 40.34 while RARE 8-day exponential moving average is 40.89, which is a Sell signal.
- The stock price of RARE is 40.34 while Ultragenyx Pharmaceutical 20-day EMA is 41.87, which makes it a Sell.
- Ultragenyx Pharmaceutical 50-day exponential moving average is 43.73 while RARE share price is 40.34, making it a Sell technically.
- RARE stock price is 40.34 and Ultragenyx Pharmaceutical 200-day simple moving average is 44.05, creating a Sell signal.
Fundamental Analysis of Ultragenyx Pharmaceutical
Is Ultragenyx Pharmaceutical a good investment?
- Analysts estimate an earnings increase this quarter of $0.46 per share, an increase next quarter of $0.08 per share, an increase this year of $0.87 per share, and an increase next year of $1.24 per share.
Technical Analysis of Ultragenyx Pharmaceutical
Should I short Ultragenyx Pharmaceutical stock?
- RARE Moving Average Covergence Divergence (MACD) indicator is -1.15, suggesting Ultragenyx Pharmaceutical is a Sell
- Ultragenyx Pharmaceutical Relative Strength Index (RSI) is 38.4, which suggest Ultragenyx Pharmaceutical is oversold
- The Bollinger Bands (25) for Ultragenyx Pharmaceutical is (40.86 - 43.66), which suggest Ultragenyx Pharmaceutical is a Sell
- The Bollinger Bands (100) for Ultragenyx Pharmaceutical is (42.61 - 49.17), which suggest Ultragenyx Pharmaceutical is a Sell
* Ultragenyx Pharmaceutical stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.